Abstract
The present invention provides compounds and compositions containing reduced nicotinamide riboside for use in methods of prevention and/or treatment of pancreatic disease and/or conditions. In one embodiment of the invention, said compounds and compositions of the invention maintain or improve pancreatic tissue function. In another embodiment of the invention, compounds and compositions of the invention may be used in methods to prevent and/or treat pancreatic diseases and/or conditions such as: acute or chronic pancreatitis; pancreatitis associated with diabetes mellitus, cystic fibrosis, or exocrine pancreatic insufficiency or hereditary pancreatitis; pancreatic cancer; and/or recovery after pancreatic injury or surgery.
| Original language | English |
|---|---|
| Patent number | US2023138327 |
| IPC | A61P 29/ 00 A I |
| Priority date | 9/03/21 |
| Publication status | Published - 4 May 2023 |